<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Trump administration announces drug pricing deals with Teva, Astellas and others — Live Feed</title><link>https://www.live-feeds.com/feed/trump-administration-announces-drug-pricing-deals-with-teva-astellas-and-others</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/trump-administration-announces-drug-pricing-deals-with-teva-astellas-and-others/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Trump administration secures drug pricing deals with 9 pharmaceutical firms</title><link>https://www.live-feeds.com/feed/trump-administration-announces-drug-pricing-deals-with-teva-astellas-and-others</link><guid isPermaLink="false">https://www.live-feeds.com/feed/trump-administration-announces-drug-pricing-deals-with-teva-astellas-and-others#u53972</guid><pubDate>Tue, 01 Sep 2026 12:37:27 +0000</pubDate><description>The Trump administration announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies on Monday. These deals ensure drugs are provided at the lowest prices available anywhere. This expansion brings the total number of companies in the administration&amp;#039;s most-favored-nation pricing program to 26. Trump claims this broader prescription drug pricing initiative will save Americans $600 billion. The move aims to ease overall drug costs by leveraging the most-favored-nation pricing model across a larger group of manufacturers.Why it mattersThe admini</description></item>
</channel></rss>